Mild hyperhomocysteinemia is associated with increased TAFI levels and reduced plasma fibrinolytic potential
Open Access
- 18 August 2008
- journal article
- Published by Elsevier BV in Journal of Thrombosis and Haemostasis
- Vol. 6 (9), 1571-1577
- https://doi.org/10.1111/j.1538-7836.2008.03070.x
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Hyperhomocysteinemia and Venous ThrombosisSeminars in Hematology, 2007
- Fibrin clot structure in patients with end-stage renal diseaseThrombosis and Haemostasis, 2007
- Homocysteine and Methionine Metabolism in Renal FailureSeminars in Vascular Medicine, 2005
- Homocysteine and thrombosis: from basic science to clinical evidenceThrombosis and Haemostasis, 2005
- Comparison of Effects of Different Heparins on Thrombin Activatable Fibrinolysis Inhibitor in Hemodialyzed PatientsAmerican Journal of Nephrology, 2004
- Hyperprothrombinemia associated with prothrombin G20210A mutation inhibits plasma fibrinolysis through a TAFI-mediated mechanismBlood, 2004
- Thrombin activatable fibrinolysis inhibitor (TAFI) affects fibrinolysis in a plasminogen activator concentration-dependent mannerThrombosis and Haemostasis, 2004
- Hyperhomocysteinemia in cerebral vein thrombosisBlood, 2003
- Hyperhomocysteinemia and Hypofibrinolysis in Young Adults With Ischemic StrokeStroke, 1999
- Thrombin-dependent inhibition of fibrinolysisCurrent Opinion in Hematology, 1996